Manulife (Manufacturers Life Insurance)
PGNX

Manulife (Manufacturers Life Insurance)’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-56,789
Closed -$216K – 3008
2020
Q1 		$216K Buy
56,789
+3,923
+7% +$16.9K ﹤0.01% 2281
2019
Q4 		$269K Sell
52,866
-2,418
-4% -$12.8K ﹤0.01% 2403
2019
Q3 		$290K Hold
55,284
– – ﹤0.01% 2340
2019
Q2 		$341K Sell
55,284
-2,901
-5% -$14K ﹤0.01% 2287
2019
Q1 		$270K Buy
58,185
+4,038
+7% +$18.3K ﹤0.01% 2295
2018
Q4 		$227K Sell
54,147
-3,125
-5% -$15.9K ﹤0.01% 2253
2018
Q3 		$359K Sell
57,272
-9,872
-15% -$75.8K ﹤0.01% 2463
2018
Q2 		$540K Buy
67,144
+3,280
+5% +$25K ﹤0.01% 2320
2018
Q1 		$476K Buy
63,864
+1,484
+2% +$9.87K ﹤0.01% 2372
2017
Q4 		$370K Buy
62,380
+1,326
+2% +$8.06K ﹤0.01% 2524
2017
Q3 		$450K Buy
61,054
+454
+0.7% +$2.88K ﹤0.01% 2344
2017
Q2 		$412K Buy
60,600
+1,868
+3% +$13.8K ﹤0.01% 2439
2017
Q1 		$555K Buy
58,732
+24,009
+69% +$240K ﹤0.01% 2109
2016
Q4 		$299K Sell
34,723
-18,053
-34% -$133K ﹤0.01% 2478
2016
Q3 		$334K Buy
52,776
+209
+0.4% +$1.26K ﹤0.01% 2380
2016
Q2 		$221K Buy
52,567
+5,118
+11% +$24.7K ﹤0.01% 2637
2016
Q1 		$202K Buy
47,449
+277
+0.6% +$1.23K ﹤0.01% 2598
2015
Q4 		$289 Buy
47,172
+510
+1% +$3.34K ﹤0.01% 2393
2015
Q3 		$267 Buy
46,662
+546
+1% +$4.19K ﹤0.01% 2423
2015
Q2 		$344 Sell
46,116
-337
-0.7% -$2.04K ﹤0.01% 2397
2015
Q1 		$278 Buy
46,453
+985
+2% +$6.2K ﹤0.01% 2491
2014
Q4 		$343 Buy
45,468
+1,755
+4% +$10.5K ﹤0.01% 2243
2014
Q3 		$227 Sell
43,713
-791
-2% -$3.94K ﹤0.01% 2561
2014
Q2 		$192K Sell
44,504
-1,462
-3% -$5.58K ﹤0.01% 2739
2014
Q1 		$188 Sell
45,966
-510
-1% -$2.61K ﹤0.01% 2768
2013
Q4 		$248 Buy
46,476
+3,126
+7% +$13.8K ﹤0.01% 2563
2013
Q3 		$218 Buy
43,350
+477
+1% +$2.59K ﹤0.01% 2592
2013
Q2 		$192K Buy
+42,873
New +$192K ﹤0.01% 2596

Other funds holding PGNX

ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s PGNX Position: Q2 2020 in Review

Manulife (Manufacturers Life Insurance) sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 56,789 shares — an estimated $216K sold.

Manulife (Manufacturers Life Insurance) first reported a position in PGNX in Q2 2013 and held it in 28 quarters. The position peaked at $555K in Q1 2017. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • Manulife (Manufacturers Life Insurance) reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 56,789 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $216K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Progenics Pharmaceuticals Inc in Q2 2013 and held it in 28 quarters.
  • Manulife (Manufacturers Life Insurance)'s Progenics Pharmaceuticals Inc position peaked at $555K in Q1 2017.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2020, filed 10 Aug 2020.